• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Bone Health and Osteoporosis Foundation
  • Product
    • How it Works
    • The Benefits
    • Warranty and Rental Program
    • Patents & Intellectual Property
    • Order Now
  • Research
  • Testimonials
  • About
    • Mission, History and Values
    • Medical / Scientific Advisors
    • Executive Team
  • Home
  • Blog
  • FAQ
  • Contact
    • Try a Juvent for FREE
  • Shop Now
  • 1.877.758.8368

Board of Directors

Rush Simonson, Chairman

rush-simonsonMr. Simonson has been involved in finance and healthcare for over 20 years.  Mr. Simonson became well known in the spinal industry following the founding of a medical distributorship for Medtronic, Inc. that was acquired by Medtronic. He is an inventor and holds 3 pioneer patents for posterior lumbar spinal artificial disks and has experience developing biomedical intellectual property. He was the founding CEO and Director of Cytonics Corporation (“Cytonics”), a proteomics discovery start-up. During his tenure at Cytonics, he led a national team of scientists from Stanford University and the University of Pittsburgh, to discover the novel protein complex believed to be responsible for back and joint pain. Mr. Simonson initiated partnership discussions that recently resulted in a 20% acquisition by Synthes/J&J. He graduated from Florida Atlantic University with a BBA (Entrepreneurial Studies and Finance). Has also completed an advanced management development program at Harvard’s Kennedy School and is well versed in the fields of protein discovery, stem cell and regenerative medicine, medical expert, and IT systems.

Peter M. Simonson, Director

peter-simonson-juventWith 20 years of executive experience in sales, marketing, management, product development, engineering, business development, market research, and consulting, Mr. Simonson holds a Mechanical Engineering degree from Georgia Tech.

He has been awarded five patents for surgical products, with an additional seven patents pending. He is the inventor of Medtronic’s patented unique spinal implant system, TSRH-3D®, which has sold in excess of $1 billion in more the 30 countries. Mr. Simonson and the team developing his technology received Medtronic’s global Technical-Contributor-of-The-Year award. Mr. Simonson has become highly sought after worldwide for his talents as a sales trainer and motivational speaker. After proving his skills invaluable in more than 60 markets, Medtronic now features his pioneering sales techniques in sales training videos and curriculum worldwide.

 

Footer

  • Home
  • User Testimonials
  • Medical Research
  • Contact
  • FAQs
  • Order Now
  • About
  • Benefits
  • Press
  • Blog
  • Privacy Policy

 


 

In the US it is considered investigational for the treatment of osteoporosis or improvement/maintenance of bone mineral density and our claims have not been reviewed or cleared by the FDA to treat any disease or condition. (2) Calculated over the 20+ year expected life of a Juvent. The JUVENT® Micro-Impact Platform® is Registered as a Class I medical device for exercise and rehabilitation. JUVENT products are covered by the following issued patents, pending patents and their foreign equivalents: 6,843,776 6,884,2277,094211 7,207,954 7,207,955 7,985,191 8,114,036 11/369,611 11/486,538. Juvent, Dynamic Motion Therapy, Micro-Impact Platform, and the symbol are Registered trademarks of Regenerative Technologies Corporation.

Juvent Clinical Studies Request

We protect and keep any given information confidentially.
  • This field is for validation purposes and should be left unchanged.

Juvent Health E-mail Signup

Get news, product updates and special offers in your inbox each month for free!

  • This field is for validation purposes and should be left unchanged.